antiphospholipid (aPL) antibodies and/or vasculitis, and it has been suggested that aPL
antibodies may play a pathogenetic role in skin manifestations of SLE. To our knowledge,
there is only one report of an aPL antibody-negative patient who developed pyoderma
gangrenosum (PG) several years before the diagnosis of SLE. We describe a case of a
young male affected by SLE who developed leg ulcers diagnosed as PG in the absence of …